NPI: 1437397056 · FOREST CITY, FL 32703 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/04/2009
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/04/2009 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,113 | $2.25M |
| 2019 | 19,466 | $2.41M |
| 2020 | 16,177 | $2.82M |
| 2021 | 7,892 | $588K |
| 2022 | 11,355 | $971K |
| 2023 | 5,409 | $557K |
| 2024 | 767 | $33K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 26,688 | 1,156 | $3.20M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 21,543 | 1,555 | $2.77M |
| J1270 | Injection, doxercalciferol, 1 mcg | 11,631 | 824 | $1.69M |
| J1756 | Injection, iron sucrose, 1 mg | 4,335 | 714 | $493K |
| A4657 | Syringe, with or without needle, each | 2,211 | 1,226 | $387K |
| 83550 | 1,504 | 1,036 | $199K | |
| 83540 | 1,499 | 1,035 | $199K | |
| 85048 | 1,379 | 955 | $184K | |
| 85041 | 1,374 | 955 | $184K | |
| 82728 | 801 | 554 | $125K | |
| 83970 | 851 | 601 | $117K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 153 | 80 | $24K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 92 | 72 | $18K |
| 82108 | 86 | 66 | $18K | |
| G0008 | Administration of influenza virus vaccine | 16 | 15 | $4K |
| 90674 | 16 | 15 | $4K |